Erfolgreicher Auftakt in Bielefeld
Protagen AG joins RA-MAP Consortium to support Identification of Predictors of Remission in Rheumatoid Arthritis (RA)
Newcastle and Dortmund, 21st January 2016 Protagen AG, a company concerned with the development of advanced diagnostic tools to address some of the most severe autoimmune diseases, has today announced that it will...
Dortmund 10th December 2015: Protagen AG, technology leader in the development of novel molecular diagnostics and companion diagnostic concepts for autoimmune diseases, announced today the formation of its Scientific Advisory...
Co-operation with Greiner Bio-One started in November 2016
DECHEMA / VBU organisiert Webinar
Presseinformation, Freitag, 02. Oktober 2015